AKT regulation of estrogen receptor beta transcriptional activity in breast cancer

Bich N Duong1, Steven Elliott, Daniel E Frigo

  • 1Center for Bioenvironmental Research, Tulane University, New Orleans, LA, USA.

Cancer Research
|September 5, 2006
PubMed

Insights

The AKT pathway enhances estrogen receptor beta (ER beta) activity, particularly its activation function-2 domain, by interacting with coactivators like GRIP1. This cross-talk may impact breast cancer endocrine therapy response.

Area of Science:

  • Molecular and Cellular Biology
  • Endocrinology
  • Oncology

Background:

  • Growth factor signaling via the PI3K-AKT pathway influences estrogen receptor alpha (ER alpha) activity and tamoxifen resistance in breast cancer.
  • The role of the PI3K-AKT pathway in regulating the transcriptional activity of estrogen receptor beta (ER beta) remains largely unexplored.

Purpose of the Study:

  • To investigate the regulation of ER beta transcriptional activity by the PI3K-AKT signaling pathway.
  • To elucidate the specific domains and coactivators involved in AKT-mediated ER beta regulation.

Main Methods:

  • Analysis of breast cancer tissue arrays to correlate AKT and ER beta expression.
  • Reporter gene assays with pharmacologic and molecular AKT inhibitors and activators.
  • Mammalian two-hybrid and one-hybrid assays to assess protein-protein interactions and domain activity.
  • In vitro kinase assays to determine direct phosphorylation events.

Main Results:

  • A positive association between AKT and ER beta expression was observed in clinical breast cancer specimens.
  • AKT was found to potentiate ER beta transcriptional activity, primarily through the activation function-2 (AF2) domain, requiring residue K269.
  • AKT enhanced the recruitment of coactivators steroid receptor coactivator 1 (SRC1) and glucocorticoid receptor-interacting protein 1 (GRIP1) to ER beta.
  • AKT directly phosphorylated GRIP1, and AKT and GRIP1 cooperatively increased ER beta-mediated transcription.

Conclusions:

  • The PI3K-AKT pathway directly regulates ER beta transcriptional activity, involving its AF2 domain and coactivators like GRIP1.
  • AKT's phosphorylation of GRIP1 and enhanced coactivator recruitment highlight a significant cross-talk between PI3K-AKT and ER beta signaling.
  • This intricate cross-talk may represent a critical factor influencing breast cancer progression and response to endocrine therapies.

Related Concept Videos

Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Regulation of Expression at Multiple Steps01:23

Regulation of Expression at Multiple Steps

The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the addition of a...
Regulation of Expression Occurs at Multiple Steps02:24

Regulation of Expression Occurs at Multiple Steps

Gene expression can be regulated at almost every step from gene to protein. Transcription is the step that is most commonly regulated. This involves the binding of proteins to short regulatory sequences on the DNA. This association can either promote or inhibit the transcription of a gene associated with the respective sequence.
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
Regulation of Expression Occurs at Multiple Steps02:24

Regulation of Expression Occurs at Multiple Steps

Gene expression can be regulated at almost every step from gene to protein. Transcription is the step that is most commonly regulated. This involves the binding of proteins to short regulatory sequences on the DNA. This association can either promote or inhibit the transcription of a gene associated with the respective sequence.
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...